» Articles » PMID: 16621245

Differential Effects of Bisphosphonates on Breast Cancer Cell Lines

Overview
Journal Cancer Lett
Specialty Oncology
Date 2006 Apr 20
PMID 16621245
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Bisphosphonates may induce direct anti-tumor effects in breast cancer cells in vitro. In this study, six bisphosphonates were administered to three breast cancer cell lines. Cell proliferation was measured by quantification of the expression of Cyclin D1 mRNA. Apoptosis was determined by flow cytometry of a DNA fragmentation assay. We demonstrated that bisphosphonates have direct effects on cell proliferation and apoptosis in different breast cancer cell lines. However, not all bisphosphonates act equally on breast cancer cells in vitro. Zoledronate seems to be the most potent of the six bisphosphonates. This in vitro study showed that bisphosphonates possess promising anti-tumor potential.

Citing Articles

Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer.

Glass K, Fines C, Coulter P, Jena L, McCarthy H, Buckley N Mol Pharm. 2024; 21(10):4970-4982.

PMID: 39196792 PMC: 11462496. DOI: 10.1021/acs.molpharmaceut.4c00299.


Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy.

Clements M, Holtslander L, Johnson J, Johnson R JBMR Plus. 2023; 7(3):e10694.

PMID: 36936362 PMC: 10020917. DOI: 10.1002/jbm4.10694.


Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.

Peng R, Liang X, Zhang G, Yao Y, Chen Z, Pan X Biomed Res Int. 2020; 2020:5606573.

PMID: 33102580 PMC: 7568169. DOI: 10.1155/2020/5606573.


Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.

Gschwantler-Kaulich D, Weingartshofer S, Grunt T, Mairhofer M, Tan Y, Gamper J PLoS One. 2017; 12(9):e0185566.

PMID: 28945801 PMC: 5612728. DOI: 10.1371/journal.pone.0185566.


The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.

Fragni M, Bonini S, Bettinsoli P, Bodei S, Generali D, Bottini A Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(5):529-38.

PMID: 26905520 DOI: 10.1007/s00210-016-1224-8.